40 related articles for article (PubMed ID: 38499636)
1. Prognosis significance and potential association between ALDOA and AKT expression in colorectal cancer.
Xu M; Xi S; Li H; Xia Y; Mei G; Cheng Z
Sci Rep; 2024 Mar; 14(1):6488. PubMed ID: 38499636
[TBL] [Abstract][Full Text] [Related]
2. Fructose-bisphosphate aldolase A is a key regulator of hypoxic adaptation in colorectal cancer cells and involved in treatment resistance and poor prognosis.
Kawai K; Uemura M; Munakata K; Takahashi H; Haraguchi N; Nishimura J; Hata T; Matsuda C; Ikenaga M; Murata K; Mizushima T; Yamamoto H; Doki Y; Mori M
Int J Oncol; 2017 Feb; 50(2):525-534. PubMed ID: 28000858
[TBL] [Abstract][Full Text] [Related]
3. High expression of ALDOA and DDX5 are associated with poor prognosis in human colorectal cancer.
Dai L; Pan G; Liu X; Huang J; Jiang Z; Zhu X; Gan X; Xu Q; Tan N
Cancer Manag Res; 2018; 10():1799-1806. PubMed ID: 29988738
[TBL] [Abstract][Full Text] [Related]
4. Aldolase A Promotes Colorectal Cancer Progression through Targeting COPS6 and Regulating MAPK Signaling Pathway.
Lu Y; Zhang Y; Wang X; Zhang H; Zhu Y; Zhang J; Sha H; Zou R; Gan Y; Sui Y; Wang J; Du T; Wu J; Feng J
Dis Markers; 2023; 2023():1702125. PubMed ID: 37457886
[TBL] [Abstract][Full Text] [Related]
5. Bioinformatics analysis of the role of aldolase A in tumor prognosis and immunity.
Tian W; Zhou J; Chen M; Qiu L; Li Y; Zhang W; Guo R; Lei N; Chang L
Sci Rep; 2022 Jul; 12(1):11632. PubMed ID: 35804089
[TBL] [Abstract][Full Text] [Related]
6. Aldolase A promotes epithelial-mesenchymal transition to increase malignant potentials of cervical adenocarcinoma.
Saito Y; Takasawa A; Takasawa K; Aoyama T; Akimoto T; Ota M; Magara K; Murata M; Hirohashi Y; Hasegawa T; Sawada N; Saito T; Osanai M
Cancer Sci; 2020 Aug; 111(8):3071-3081. PubMed ID: 32530543
[TBL] [Abstract][Full Text] [Related]
7. Protein kinase B (Akt) blockade inhibits LH/hCG-mediated 17,20-lyase, but not 17α-hydroxylase activity of Cyp17a1 in mouse Leydig cell steroidogenesis.
Paradiso E; Lazzaretti C; Sperduti S; Melli B; Trenti T; Tagliavini S; Roli L; D'Achille F; Beltrán-Frutos E; Simoni M; Casarini L
Cell Signal; 2023 Nov; 111():110872. PubMed ID: 37640196
[TBL] [Abstract][Full Text] [Related]
8. Colorectal cancer statistics, 2023.
Siegel RL; Wagle NS; Cercek A; Smith RA; Jemal A
CA Cancer J Clin; 2023; 73(3):233-254. PubMed ID: 36856579
[TBL] [Abstract][Full Text] [Related]
9. Bibliometric analysis of the 100 most-cited papers about the role of gut microbiota in irritable bowel syndrome from 2000 to 2021.
Wan C; Kong X; Liao Y; Chen Q; Chen M; Ding Q; Liu X; Zhong W; Xu C; Liu W; Wang B
Clin Exp Med; 2023 Oct; 23(6):2759-2772. PubMed ID: 36522553
[TBL] [Abstract][Full Text] [Related]
10. Initial clinical and experimental analyses of ALDOA in gastric cancer, as a novel prognostic biomarker and potential therapeutic target.
Chen L; Wu Z; Guo J; Wang X; Zhao Z; Liang H; Zhang R; Deng J
Clin Exp Med; 2023 Oct; 23(6):2443-2456. PubMed ID: 36422738
[TBL] [Abstract][Full Text] [Related]
11. Aldolase A promotes cell proliferation and cisplatin resistance via the EGFR pathway in gastric cancer.
Gu M; Jiang B; Li H; Zhu D; Jiang Y; Xu W
Am J Transl Res; 2022; 14(9):6586-6595. PubMed ID: 36247245
[TBL] [Abstract][Full Text] [Related]
12. Clinical Updates for Colon Cancer Care in 2022.
Fabregas JC; Ramnaraign B; George TJ
Clin Colorectal Cancer; 2022 Sep; 21(3):198-203. PubMed ID: 35729033
[TBL] [Abstract][Full Text] [Related]
13. The POU2F1-ALDOA axis promotes the proliferation and chemoresistance of colon cancer cells by enhancing glycolysis and the pentose phosphate pathway activity.
Lin J; Xia L; Oyang L; Liang J; Tan S; Wu N; Yi P; Pan Q; Rao S; Han Y; Tang Y; Su M; Luo X; Yang Y; Chen X; Yang L; Zhou Y; Liao Q
Oncogene; 2022 Feb; 41(7):1024-1039. PubMed ID: 34997215
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
